✦ LIBER ✦

Lack of alloimmunization to D antigen in D-negative immunosuppressed liver transplant recipients

✍ Scribed by M. Casanueva; M.D. Valdes; M.C. Ribera

Book ID: 114439846
Publisher: Elsevier Science
Year: 1994
Tongue: English
Weight: 264 KB
Volume: 34
Category: Article
ISSN: 0372-1248
DOI: 10.1046/j.1537-2995.1994.34794330009.x

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Alloimmunization to D antigen and HLA in

Alloimmunization to D antigen and HLA in D-negative immunosuppressed oncology patients

✍ M.L. Baldwin; P.M. Ness; D. Scott; H. Braine; T.S. Kickler 📂 Article 📅 1988 🏛 Elsevier Science 🌐 English ⚖ 317 KB

Low risk of alloimmunization to the D an

Low risk of alloimmunization to the D antigen in D− orthotopic liver transplant recipients receiving D+ RBCs perioperatively

✍ Shan Yuan; Rebecca Davis; Qun Lu; Dennis Goldfinger; Alyssa F. Ziman 📂 Article 📅 2008 🏛 Elsevier Science 🌐 English ⚖ 90 KB

Severe hemolysis due to anti-D in a D-ne

Severe hemolysis due to anti-D in a D-negative recipient of an orthotopic liver transplant

✍ Cecily Forsyth; Hazel Popp; Harry Kronenberg; Geoff McCaughan 📂 Article 📅 1995 🏛 Elsevier Science 🌐 English ⚖ 112 KB

Rh(D) Alloimmunization in the Absence of

Rh(D) Alloimmunization in the Absence of Exposure to Rh(D) Antigen

✍ Kieran R. Biggins; John M. Bowman 📂 Article 📅 1986 🏛 John Wiley and Sons 🌐 English ⚖ 223 KB

Lack of association between HLA antigen

Lack of association between HLA antigen DR3 and α1deficiency in liver transplant recipients

✍ Adrian Casavilla; Robert Gordon; David H. Van Thiel; Thomas E. Starzl 📂 Article 📅 1993 🏛 Springer US 🌐 English ⚖ 272 KB

Failure of vaccination against hepatitis

Failure of vaccination against hepatitis B with Gen H-B-Vax-D in immunosuppressed heart transplant recipients

✍ Wagner, D. ;Wagenbreth, I. ;Stachan-Kunstyr, R. ;Flik, J. 📂 Article 📅 1992 🏛 Springer-Verlag 🌐 English ⚖ 283 KB

Some 86 heart transplant recipients under immunosuppressive therapy were vaccinated against hepatitis B using the vaccine Gen H-B-Vax-D, but 95.3% failed to develop protective levels of HBs-specific antibody (more than 10 U/l) after the third vaccination.